Symbol="ARWR"
AssetType="Common Stock"
Name="Arrowhead Pharmaceuticals Inc"
Description="Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California."
CIK="879407"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="TRADE & SERVICES"
Industry="SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH"
Address="225 SOUTH LAKE AVENUE, SUITE 1050, PASADENA, CA, US"
FiscalYearEnd="September"
LatestQuarter="2023-06-30"
MarketCapitalization="3101169000"
EBITDA="-140096000"
PERatio="None"
PEGRatio="-1.32"
BookValue="4.181"
DividendPerShare="0"
DividendYield="0"
EPS="-1.44"
RevenuePerShareTTM="2.571"
ProfitMargin="-0.551"
OperatingMarginTTM="-0.552"
ReturnOnAssetsTTM="-0.118"
ReturnOnEquityTTM="-0.332"
RevenueTTM="272800000"
GrossProfitTTM="243231000"
DilutedEPSTTM="-1.44"
QuarterlyEarningsGrowthYOY="0.098"
QuarterlyRevenueGrowthYOY="-0.036"
AnalystTargetPrice="59.69"
TrailingPE="-"
ForwardPE="111.11"
PriceToSalesRatioTTM="14.71"
PriceToBookRatio="8.04"
EVToRevenue="11.97"
EVToEBITDA="-17.32"
Beta="0.957"
num_52WeekHigh="48.48"
num_52WeekLow="23.09"
num_50DayMovingAverage="34.59"
num_200DayMovingAverage="33.14"
SharesOutstanding="106900000"
DividendDate="None"
ExDividendDate="None"
symbol="ARWR"
open="27.50"
high="29.36"
low="27.28"
price="29.01"
volume="1488346.00"
latest_trading_day="2023-08-09"
previous_close="27.49"
change="1.52"
change_percent="5.5293%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="46"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="54"
Volume_recent_avg="1003386"
Change_recent_avg="-0.07"
Delta_recent_avg="1.32"
Variance_recent_avg="0.66"
Change_ratio_recent_avg="-0.21"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="54"
Aroon_momentum_negative="46"
image_negative_thumbnail_id_1="1151"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0184.jpeg"
image_negative_thumbnail_id_2="154"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0022.jpeg"
image_neutral_thumbnail_id_1="526"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0073.jpeg"
image_neutral_thumbnail_id_2="567"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0032.jpeg"
image_positive_thumbnail_id_1="615"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0093.jpeg"
image_positive_thumbnail_id_2="1005"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0167.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1201"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
